NFKB1 and hepatocellular carcinoma: By analyzing the clinical status and frequency of the NFKB1 -94 Del/Ins polymorphism in 135 HCC patients, the parameters of clinical stage, tumor size, lymph node metastasis, and distant metastasis presented no significant differences in any HCC case.